These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23917391)

  • 1. Association of biomarkers of inflammation, cartilage and bone turnover with gender, disease activity, radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis.
    Almodóvar R; Ríos V; Ocaña S; Gobbo M; Casas ML; Zarco-Montejo P; Juanola X
    Clin Rheumatol; 2014 Feb; 33(2):237-41. PubMed ID: 23917391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
    Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY; Jung JY; Hong YS; Ju JH; Park SH
    Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.
    Soliman E; Labib W; el-Tantawi G; Hamimy A; Alhadidy A; Aldawoudy A
    Rheumatol Int; 2012 Jun; 32(6):1711-20. PubMed ID: 21431945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
    Pedersen SJ; Sørensen IJ; Lambert RG; Hermann KG; Garnero P; Johansen JS; Madsen OR; Hansen A; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen KH; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Østergaard M
    Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis.
    Park MC; Chung SJ; Park YB; Lee SK
    Yonsei Med J; 2008 Apr; 49(2):288-94. PubMed ID: 18452267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis.
    Maksymowych WP; Rahman P; Shojania K; Olszynski WP; Thomson GT; Ballal S; Wong RL; Inman RD;
    J Rheumatol; 2008 Oct; 35(10):2030-7. PubMed ID: 18785308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone turnover biomarkers, disease activity, and MRI changes of sacroiliac joints in patients with spondyloarthritis.
    Iaremenko O; Shynkaruk I; Fedkov D; Iaremenko K; Petelytska L
    Rheumatol Int; 2020 Dec; 40(12):2057-2063. PubMed ID: 32979065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The occurrence of sacroiliitis in HLA-B*35-positive patients with undifferentiated spondyloarthritis. A cross sectional MRI study.
    Šošo D; Aljinović J; Marinović I; Kojundžić SL; Jeličić EČ; Krstulović DM
    Clin Rheumatol; 2020 Aug; 39(8):2299-2306. PubMed ID: 32107663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters.
    Konca S; Keskin D; Cılız D; Bodur H; Sakman B
    Rheumatol Int; 2012 Dec; 32(12):3765-70. PubMed ID: 22159818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.
    Arends S; Spoorenberg A; Bruyn GA; Houtman PM; Leijsma MK; Kallenberg CG; Brouwer E; van der Veer E
    Osteoporos Int; 2011 May; 22(5):1431-9. PubMed ID: 20603707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.
    Maksymowych WP; Landewé R; Conner-Spady B; Dougados M; Mielants H; van der Tempel H; Poole AR; Wang N; van der Heijde D
    Arthritis Rheum; 2007 Jun; 56(6):1846-53. PubMed ID: 17530713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomic Quantification for MRI Assessment of Sacroiliac Joints of Patients with Spondyloarthritis.
    Tenório APM; Ferreira-Junior JR; Dalto VF; Faleiros MC; Assad RL; Louzada-Junior P; Nogueira-Barbosa MH; Rangayyan RM; de Azevedo-Marques PM
    J Digit Imaging; 2022 Feb; 35(1):29-38. PubMed ID: 34997373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: the Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study.
    Lorenzin M; Ortolan A; Vio S; Favero M; Oliviero F; Zaninotto M; Cosma C; Lacognata C; Punzi L; Ramonda R
    Reumatismo; 2017 Aug; 69(2):65-74. PubMed ID: 28776360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study.
    Inman RD; Baraliakos X; Hermann KA; Braun J; Deodhar A; van der Heijde D; Xu S; Hsu B
    Arthritis Res Ther; 2016 Dec; 18(1):304. PubMed ID: 28031053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.
    Navarro-Compán V; Ramiro S; Landewé R; Dougados M; Miceli-Richard C; Richette P; van der Heijde D
    Ann Rheum Dis; 2016 May; 75(5):874-8. PubMed ID: 26403689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.